In comparison with expression in mice in the control group, the expression of TGF-β1 in both BALF and serum was significantly increased in mice following BLM intervention, and QRHXF or PFD treatment significantly reduced this level (Fig. 5a, b). This evidence concerns the gene TGFB1 and polyostotic fibrous dysplasia.